E-PHARM LIMITED Financials
- Company number
- 03725304CopyCopy
- Registered office
- Unit 75 Capital Business Centre, 22 Carlton Road, South Croydon, Surrey CR2 0BS
- Incorporated
- 03/03/1999
Company snapshot
- Status
- Active
- Employees
- 6 (2025)
- Latest financial data
- 2025
- Accounts type
- Total Exemption Full
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
2024: £2.07M
Total Assets
2024: £2.51M
Cash in Bank
2024: £1.98M
Total Liabilities
2024: £428.33K
Employees
2024: 6
In 2025, E-PHARM LIMITED reported net assets of £2.16M. The same filing shows total assets of £2.44M, cash in bank of £1.82M and total liabilities of £267.20K. Reported headcount was 6 in 2025. Total Liabilities fell from £428.33K in 2024 to £267.20K in 2025 (-37.62%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures E-PHARM LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
+8.1% a year compound (CAGR)
Cash in Bank
+15.8% a year compound (CAGR)
Total Assets
+3.4% a year compound (CAGR)
Total Liabilities
-20.7% a year compound (CAGR)
Employees
Biggest increase
Cash in Bank+34.2%
£1.35M in 2023 to £1.82M in 2025
Biggest decrease
Total Liabilities-37.1%
£424.71K in 2023 to £267.20K in 2025
E-PHARM LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in cash in bank, pointing to a more liquid cash position, set against a fall in total liabilities, pointing to lighter outstanding obligations. See the full year-by-year figures.
Ratios from the filed figures
Calculated from E-PHARM LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- 88.44%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 10.94%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
- Cash to liabilities
- 679.74%2025
- Reported cash in bank divided by total liabilities for the same year. Shows what share of outstanding obligations the reported cash balance would cover.
- Cash to total assets
- 74.38%2025
- Reported cash in bank divided by reported total assets, for the latest year both were filed.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for E-PHARM LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 1.36M | 1.43M | 1.85M | 2.07M | 2.16M |
| Total Assets£ | 1.97M | 1.84M | 2.28M | 2.51M | 2.44M |
| Cash in Bank£ | 1.39M | 916.05K | 1.35M | 1.98M | 1.82M |
| Total Liabilities£ | 591.86K | 397.80K | 424.71K | 428.33K | 267.20K |
| Employees | 5 | 5 | 5 | 6 | 6 |
E-PHARM LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for E-PHARM LIMITED covering 2021–2025, across 5 reported indicators. The most recent reported year is 2025.
E-PHARM LIMITED reported net assets of £2.16M for 2025. That compares with £2.07M in 2024, a change of 4.55%.
E-PHARM LIMITED reported total assets of £2.44M for 2025. That compares with £2.51M in 2024, a change of -2.63%.
E-PHARM LIMITED reported cash in bank of £1.82M for 2025. That compares with £1.98M in 2024, a change of -8.12%.
E-PHARM LIMITED reported 6 employees in 2025, compared with 6 in 2024.
Between 2023 and 2025, E-PHARM LIMITED's net assets rose by 16.8%, cash in bank rose by 34.2%, total assets rose by 6.9% and total liabilities fell by 37.1%. Net assets compounded at 8.1% a year across the two years to 2025, from £1.85M to £2.16M. Reported headcount went from 5 in 2023 to 6 in 2025 (+1).
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.